Keyphrases
4-fold
6%
Autoimmune Disease
50%
Cancer Risk
6%
Clinical Features
6%
Environmental Factors
6%
High Disease Activity
12%
High Risk
6%
Immune Stimulation
50%
Immune Suppression
50%
Immune System
6%
Innovative Research
6%
Lupus Low Disease Activity State (LLDAS)
12%
Lymphoma
50%
Lymphomagenesis
6%
Overactivity
12%
Pathological Features
6%
SLE Disease Activity Index (SLEDAI)
12%
Systemic Lupus Erythematosus
37%
Systemic Lupus Erythematosus Patient
12%
Viral Infection
6%
Medicine and Dentistry
Autoimmune Disease
50%
Cancer Risk
5%
Disease Activity
16%
Drug Therapy
5%
Environmental Factor
5%
Immune System
5%
Immunostimulation
100%
Immunosuppressive Treatment
50%
Lupus Erythematosus
5%
Malignant Neoplasm
11%
Population
5%
Systemic Lupus Erythematosus
50%
Virus Infection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Disease
100%
Disease Activity
33%
Malignant Neoplasm
22%
Systemic Lupus Erythematosus
100%
Virus Infection
11%